Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 8

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 8
---
 superior to the Alcon merger, or that such competitive process will
result in an increase to the merger consideration payable by Alcon, and STAAR may be unable to obtain the votes required to approve the Merger Proposal and the Compensation Proposal in the absence of any change to the terms of the Merger
Agreement. The proxy contest resulting from the Broadwood Group filing will cause STAAR stockholders to incur additional solicitation and other costs, and may impair STAAR’s ability to obtain the votes required to approve the Merger
Proposal and Compensation Proposal.

Set forth below are further supplemental disclosures with respect to the “Background of the Merger” section of the proxy statement to reflect relevant developments that have occurred since the filing of the supplement to the proxy statement dated November 17, 2025 (the “Prior Supplement”).

Supplemental Disclosures to the Proxy Statement in Connection with the Background of the Merger

The proxy statement describes the background of the Merger up to and including November 17, 2025, and is hereby amended by inserting the following text below the final paragraph on page 13 of the Prior Supplement:

On November 21, 2025, Broadwood filed a Schedule 13D/A announcing it had acquired beneficial ownership, as of November 21, 2025, of 30.2% of the outstanding shares of STAAR common stock.

During the go-shop period that began on November 7, 2025, STAAR, with the assistance of its financial advisor, Citi, actively solicited acquisition proposals from a wide range of potentially interested third parties – including financial sponsors, potential strategic acquirers and the parties previously identified in the proxy statement as Party A, Party B and Party C. In total, STAAR or Citi engaged with 21 parties. Two of the 21 parties signed nondisclosure agreements and were provided diligence information by STAAR, but none of the 21 parties submitted an Acquisition Proposal during the go-shop period.

On December 2, 2025, Broadwood filed an amendment to its Schedule 13D disclosing that it was undertaking the steps required to call a special meeting of STAAR’s stockholders in order to propose the removal of three of STAAR’s six Board members.

7

On December 5, 2025, Mr. Endicott and Mr. Farrell discussed the status of Alcon’s investor outreach efforts. Mr. Endicott also indicated to Mr. Farrell that Gibson Dunn would send a draft of a